HCH6-1 is a selective competitive antagonist of formyl peptide receptor 1 (FPR1) and has protective effects against acute lung injury (ALI). HCH6-1 may have potential as a new therapeutic agent for treating FPR1-involved inflammatory lung diseases.
[1] Shun-Chin Yang, et al. Free Radic Biol Med. 2017 May;106:254-269.
















